140 related articles for article (PubMed ID: 8397394)
1. Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time.
Koch KM; Parr AF; Tomlinson JJ; Sandefer EP; Digenis GA; Donn KH; Powell JR
Pharm Res; 1993 Jul; 10(7):1027-30. PubMed ID: 8397394
[TBL] [Abstract][Full Text] [Related]
2. The effects of pharmaceutical excipients on small intestinal transit.
Adkin DA; Davis SS; Sparrow RA; Huckle PD; Phillips AJ; Wilding IR
Br J Clin Pharmacol; 1995 Apr; 39(4):381-7. PubMed ID: 7640144
[TBL] [Abstract][Full Text] [Related]
3. [Bioequivalence and bioavailability after single administration of effervescent ranitidine tablets].
Hartmann B; Schmieder G; Tetzloff W; Töberich H
Arzneimittelforschung; 1992 Aug; 42(8):1020-2. PubMed ID: 1418073
[TBL] [Abstract][Full Text] [Related]
4. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
Lee HT; Lee YJ; Chung SJ; Shim CK
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
[TBL] [Abstract][Full Text] [Related]
5. Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption.
Schulze JD; Waddington WA; Eli PJ; Parsons GE; Coffin MD; Basit AW
Pharm Res; 2003 Dec; 20(12):1984-8. PubMed ID: 14725363
[TBL] [Abstract][Full Text] [Related]
6. The use of formulation technology to assess regional gastrointestinal drug absorption in humans.
Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF
Eur J Pharm Sci; 2004 Feb; 21(2-3):179-89. PubMed ID: 14757489
[TBL] [Abstract][Full Text] [Related]
7. Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine.
Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF
Pharm Res; 2002 Sep; 19(9):1368-74. PubMed ID: 12403075
[TBL] [Abstract][Full Text] [Related]
8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
9. Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humans.
Mojaverian P; Vlasses PH; Parker S; Warner C
Clin Pharmacol Ther; 1990 Mar; 47(3):382-8. PubMed ID: 2178854
[TBL] [Abstract][Full Text] [Related]
10. Effect of gastric emptying and entero-hepatic circulation on bioequivalence assessment of ranitidine.
Chrenova J; Durisova M; Mircioiu C; Dedik L
Methods Find Exp Clin Pharmacol; 2010; 32(6):413-9. PubMed ID: 20852750
[TBL] [Abstract][Full Text] [Related]
11. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation.
Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
13. A modern view of excipient effects on bioequivalence: case study of sorbitol.
Chen ML; Straughn AB; Sadrieh N; Meyer M; Faustino PJ; Ciavarella AB; Meibohm B; Yates CR; Hussain AS
Pharm Res; 2007 Jan; 24(1):73-80. PubMed ID: 17048115
[TBL] [Abstract][Full Text] [Related]
14. Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humans.
Reynolds KS; Song MH; Heizer WD; Burns CB; Sica DA; Brouwer KL
Pharm Res; 1998 Aug; 15(8):1281-5. PubMed ID: 9706062
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers.
Bawazir SA; Gouda MW; El-Sayed YM; Al-Khamis KI; Al-Yamani MJ; Niazy EM; Al-Rashood KA
Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioequivalence study of ranitidine film tablets in healthy male subjects.
Gschwend MH; Guserle R; Erenmemişoglu A; Martin W; Tamur U; Kanzik I; Hincal AA
Arzneimittelforschung; 2007; 57(6):315-9. PubMed ID: 17688076
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability of oral dosage forms of tenoxicam.
Guentert TW; Stebler T; Banken L; Defoin R; Schmitt M
Arzneimittelforschung; 1994 Sep; 44(9):1051-4. PubMed ID: 7986242
[TBL] [Abstract][Full Text] [Related]
19. Meal-induced acceleration of tablet transit through the human small intestine.
Fadda HM; McConnell EL; Short MD; Basit AW
Pharm Res; 2009 Feb; 26(2):356-60. PubMed ID: 18982248
[TBL] [Abstract][Full Text] [Related]
20. Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology.
Watson RG; Johnston BT; Tham TC; Kersey K
Aliment Pharmacol Ther; 1996 Dec; 10(6):913-8. PubMed ID: 8971288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
